NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Phase II Clinical Trial
Explore clinical trials studying Phase II Clinical Trial. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Phase II Clinical Trial trial results
NCT04338867
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +18 more
- Locations
-
- National Cancer Institute of Mexico Mexico City, Mexico